FOR IMMEDIATE RELEASE ANNAPOLIS, MD — In a poignant and urgent dispatch from the front lines of...
Patient Advocacy and Support
The landscape of breast cancer treatment has undergone a radical transformation over the last half-century. We have...
CHICAGO — The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting has solidified a profound paradigm...
The narrative surrounding the BRCA1 and BRCA2 genetic mutations has, for decades, been framed almost exclusively as...
Introduction The month of April has proven to be a watershed moment for the healthcare advocacy community,...
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting served as a global theater for the...
LOS ANGELES, CA — As the calendar turned to June 2026, marking the beginning of Pride Month,...
By [Your Name/Journalist Name] The landscape of metastatic breast cancer (MBC) research and treatment is currently navigating...
Understanding HR-Positive Breast Cancer: The Evolution of Treatment and the New Era of Targeted Care
Understanding HR-Positive Breast Cancer: The Evolution of Treatment and the New Era of Targeted Care
The landscape of oncology is shifting. For decades, a breast cancer diagnosis was often met with a...
The landscape of oncology is undergoing a seismic shift. For decades, the primary objective of cancer treatment...
